ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
17.981,40
0,42%
S&P 500
5.104,47
0,80%
Dow Jones
38.547,20
0,84%
Euro vs US Dollar
1,07677
0,35%
Bitcoin
61.536,17
4,08%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Heron Therapeautics Inc (HRTX)

  7. Heron Therapeautics Inc (HRTX) News

HRTX Heron Therapeautics Inc

2,66
0,11 (4,31%)
Zuletzt aktualisiert: 16:56:51
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Heron Therapeautics Inc HRTX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,11 4,31% 2,66 16:56:51
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
2,67 2,6117 2,74 2,55
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
24.4.202414:00PRNUSHeron Therapeutics to Report First Quarter 2024 Financial..
11.4.202422:05PRNUSHeron Therapeutics to Host Investor Day on May 15, 2024 in..
28.3.202421:05PRNUSHeron Therapeutics Announces Presentation at the 23rd Annual..
13.3.202421:25APSBiotech Finds Mid-Week Success Following Q4 Earnings Release
12.3.202421:05PRNUSHeron Therapeutics Announces Fourth Quarter and Full-Year..
12.3.202412:22IHMARKETNEWSGlobal Markets Await U.S. Inflation Report: Mixed Movements..
28.2.202414:00PRNUSHeron Therapeutics to Report Fourth Quarter and Full Year..
14.2.202422:37EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14.2.202422:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
24.1.202415:25APSPremarket Heats Up For Biotech Before Opening Bell
24.1.202414:01EDGAR2Form 8-K - Current report
24.1.202402:00PRNUSHeron Therapeutics Announces FDA Approval of ZYNRELEF®..
20.1.202403:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.1.202403:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.1.202403:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.1.202403:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.1.202403:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.1.202403:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.1.202403:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.1.202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.1.202402:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.1.202423:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.1.202422:07EDGAR2Form 8-K - Current report
07.1.202423:00PRNUSHeron Therapeutics Announces Partnership with CrossLink Life..
22.12.202322:30EDGAR2Form 8-K - Current report
21.12.202323:25EDGAR2Form 8-K - Current report
06.12.202322:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
21.11.202318:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.11.202316:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.11.202318:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.11.202318:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.11.202318:25APSBiotech Shares Up Sharply Following Quarterly Results
14.11.202322:10EDGAR2Form 8-K - Current report
14.11.202322:05PRNUSHeron Therapeutics Announces Third Quarter 2023 Financial..
07.11.202322:05PRNUSHeron Therapeutics to Report Third Quarter 2023 Financial..
18.10.202301:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.8.202322:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.8.202322:08EDGAR2Form S-3 - Registration statement under Securities Act of..
14.8.202322:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14.8.202322:11EDGAR2Form 8-K - Current report
14.8.202322:05PRNUSHeron Therapeutics Announces Second Quarter 2023 Financial..
07.8.202322:05PRNUSHeron Therapeutics to Report Second Quarter 2023 Financial..
01.8.202319:56EDGAR2Form D - Notice of Exempt Offering of Securities
25.7.202322:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.7.202322:13EDGAR2Form SC 13D/A - General statement of acquisition of..
24.7.202315:12EDGAR2Form 8-K - Current report
24.7.202315:02PRNUSHeron Therapeutics Announces Cost Reduction Plan and..
24.7.202315:00PRNUSHeron Therapeutics Announces $30 Million Private Placement..
20.7.202300:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.7.202323:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

NASDAQ
HRTX
Heron Therapeautics
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten